Document and Entity Information
Document and Entity Information | 3 Months Ended |
Dec. 31, 2020$ / sharesshares | |
Details | |
Registrant CIK | 0001827855 |
Fiscal Year End | --09-30 |
Document Type | 10-Q |
Document Period End Date | Dec. 31, 2020 |
Document Transition Report | false |
Entity File Number | 333-250025 |
Entity Registrant Name | Medicale Corp. |
Entity Incorporation, State or Country Code | NV |
Entity Tax Identification Number | 98-1556944 |
Entity Address, Address Line One | Xibahe Beili 25 |
Entity Address, City or Town | Beijing |
Entity Address, Country | CN |
Entity Address, Postal Zip Code | 100096 |
Country Region | 1 |
City Area Code | 702 |
Local Phone Number | 4259229 |
Entity Current Reporting Status | Yes |
Entity Interactive Data Current | Yes |
Entity Filer Category | Non-accelerated Filer |
Entity Small Business | true |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity Shell Company | true |
Entity Listing, Par Value Per Share | $ / shares | $ 0.0001 |
Entity Common Stock, Shares Outstanding | shares | 3,400,000 |
Amendment Flag | false |
Document Fiscal Year Focus | 2021 |
Document Fiscal Period Focus | Q1 |
Document Quarterly Report | true |
CONDENSED BALANCE SHEETS
CONDENSED BALANCE SHEETS - USD ($) | Dec. 31, 2020 | Sep. 30, 2020 |
ASSETS | ||
Cash and cash equivalents | $ 200 | $ 200 |
Escrow account | 0 | 0 |
Total current assets | 200 | 200 |
Developed website, net | 11,400 | 12,000 |
Total Assets | 11,600 | 12,200 |
LIABILITIES | ||
Accounts Payable | 12,000 | 12,000 |
Related party accrued wages | 4,000 | 1,000 |
Related party advances | 8,517 | 603 |
Total current liabilities | 24,517 | 13,603 |
Additional paid-in-capital | 180 | 180 |
Accumulated deficit | (13,437) | (1,923) |
Total Stockholders' Equity | (12,917) | (1,403) |
Total Liabilities and Stockholders' Equity | $ 11,600 | $ 12,200 |
CONDENSED BALANCE SHEETS - Pare
CONDENSED BALANCE SHEETS - Parenthetical - $ / shares | Dec. 31, 2020 | Sep. 30, 2020 |
Details | ||
Common Stock, Par or Stated Value Per Share | $ 0.0001 | $ 0.0001 |
Common Stock, Shares Authorized | 75,000,000 | 75,000,000 |
Common Stock, Shares, Issued | 3,400,000 | |
Common Stock, Shares, Outstanding | 3,400,000 |
CONDENSED STATEMENT OF OPERATIO
CONDENSED STATEMENT OF OPERATIONS | 3 Months Ended |
Dec. 31, 2020USD ($)$ / sharesshares | |
Details | |
Revenue | $ 0 |
General and administrative expenses | 11,514 |
Net income (loss) from operations | (11,514) |
Income (Loss) before taxes | (11,514) |
Net income (loss) | $ (11,514) |
Loss per common share:, Basic and Diluted | $ / shares | $ 0 |
Weighted Average Number of Common Shares Outstanding: Basic and Diluted | shares | 3,400,000 |
Statement of Cash Flows
Statement of Cash Flows | 3 Months Ended |
Dec. 31, 2020USD ($) | |
Operating Activities | |
Net (loss) | $ (11,514) |
Accrued Expenses | 3,000 |
Accumulated Amortization | 600 |
Net cash provided operating activities | (7,914) |
Investing Activities | |
Developed Website, net | 0 |
Net cash provided by Investing Activities | 0 |
Financing Activities | |
Director loan | 7,914 |
Capital Stock | 0 |
Net cash provided by financing activities | 7,914 |
Net increase in cash and equivalents | 0 |
Cash and Cash Equivalents, at Carrying Value, Beginning Balance | 0 |
Cash and Cash Equivalents, at Carrying Value, Ending Balance | $ 0 |
NOTE 1 - ORGANIZATION AND BASIS
NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION | 3 Months Ended |
Dec. 31, 2020 | |
Notes | |
NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION | NOTE 1 ORGANIZATION AND BASIS OF PRESENTATION MEDICALE CORP. (the Company,, we, us or our) was incorporated in the State of Nevada on August 17, 2020. We plan to offer consulting services and distribution of the dietary supplements. A dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. A supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, in order to increase the quantity of their consumption. Our principal place of business is located Otar Lortkifanidze 16 |
NOTE 2 - GOING CONCERN
NOTE 2 - GOING CONCERN | 3 Months Ended |
Dec. 31, 2020 | |
Notes | |
NOTE 2 - GOING CONCERN | NOTE 2 GOING CONCERN The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (GAAP), which contemplate continuation of the Company as a going concern. The Company has an accumulated deficit of $13,437 as of December 31, 2020. The Company currently has losses and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Companys ability to continue as a going concern. Management anticipates that the Company will be dependent, for the near future, on additional investment capital to fund operating expenses. The Company intends to position itself so that it will be able to raise additional funds through the capital markets. In light of managements efforts, there are no assurances that the Company will be successful in this or any of its endeavors or become financially viable and continue as a going concern. |
Property, Plant and Equipment D
Property, Plant and Equipment Disclosure | 3 Months Ended |
Dec. 31, 2020 | |
Notes | |
Property, Plant and Equipment Disclosure | Note 4 PROPERTY, PLANT AND EQUIPMENT The Company purchased and possesses an asset in a form of an operative website with news blog. The Company purchased the website for $12,000 and is amortizing the asset straight-line over its five year useful life or $2,400 per year. During the three months ended December 31, 2020, $600 of amortization expense was recognized. Balances as of December 31, 2020 and September 30, 2020 are as follows: December 31, 2020 September 30, 2020 Intangible Assets Purchased $ 12,000 $ 12,000 Accumulated Amortization (600) - Net Book Value $ 11,400 $ 12,000 |
Note 5 - COMMON STOCK
Note 5 - COMMON STOCK | 3 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 5 - COMMON STOCK | Note 5 COMMON STOCK The Company has 75,000,000, $0.0001 par value shares of voting common stock authorized. All shares of common stock have voting rights and are identical. All holders of shares of common stock shall at every meeting of the stockholders be entitled to one vote for each share of the capital stock held by such stockholder. During the period ended September 30, 2020, the Company sold 3,200,000 shares of common stock to the Companys sole officer, director, and related party, Borisi Alborovi, for $0.0001 per share or $320. During the period ended September 30, 2020, the Company sold 200,000 shares of common stock to a non-related party for $0.001 per share or $200. As of December 31, 2020 the company had 3,400,000 shares issued and outstanding. |
Note 6 - COMMITMENTS AND CONTIN
Note 6 - COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 6 - COMMITMENTS AND CONTINGENCIES | Note 6 COMMITMENTS AND CONTINGENCIES The Company neither owns nor leases any real or personal property. An officer has provided office services without charge. There is no obligation for the officer to continue this arrangement. Such costs are immaterial to the financial statements and accordingly are not reflected herein. The officers and directors are involved in other business activities and most likely will become involved in other business activities in the future. |
Note 7 - SUBSEQUENT EVENTS
Note 7 - SUBSEQUENT EVENTS | 3 Months Ended |
Dec. 31, 2020 | |
Notes | |
Note 7 - SUBSEQUENT EVENTS | Note 7 SUBSEQUENT EVENTS In accordance with SFAS 165 (ASC 855-10) the Company has analyzed its operations subsequent to December 31, 2020 to the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements |